Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines
Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, Işıl Fidan, Gülendam Bozdayı, Feride Göğüş
Topics & Concepts
MedicineImmunogenicitySeroconversionCoronavirus disease 2019 (COVID-19)TiterSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineAntibodyImmunologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesHeparin-Induced Thrombocytopenia and Thrombosis